- Retraction Note
- Open Access
Retraction Note: Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro
Stem Cell Research & Therapy volume 13, Article number: 46 (2022)
Retraction Note: Stem Cell Research & Therapy (2017) 8:164 https://doi.org/10.1186/s13287-017-0617-z
The Editors-in-Chief have retracted this article because overlap in cell images was identified in the published Figs. 2, 3 and 6. The authors provided the original files, but the data contained further cases of duplication. The Editor-in-Chief therefore no longer has confidence in the integrity of the data in this article.
All authors agree to this retraction.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Xu, Xp., He, Hl., Hu, Sl. et al. Retraction Note: Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro. Stem Cell Res Ther 13, 46 (2022). https://doi.org/10.1186/s13287-022-02733-2